Injective
Bitcoin
Quantus
Sui
Derive
Pump.fun
Quant
- The Target Corporation stock price has given a breakdown from the falling Wedge pattern.
- The TGT stock price has declined by more than 28% in 2023.
- Tigress Financial maintained its “BUY” rating but cut the target price.
The Target Corporation Stock price has been in a strong downtrend since November 2021 and the stock price is trading with a cut of over 58% from highs. It has never changed its bearish trend since then, which is a negative sign for the investors. However, the price has consolidated in a range for about one year between this downtrend.
The TGT Stock price started the current year on a positive note. It has experienced over 21% surge within a month but has failed to sustain that upward move. Since then, the stock price has started to decline and keep on defeating the bulls at every level. It has declined by over 39% from the annual highs.
Tigress Financial has cut down the target price on the Target Corporation stock from $215 to $180 but maintained its “BUY” rating. It is an immense expectation for the stock by the rating firm, as the stock is looking weak on the chart. Furthermore, the FDA has released an advisory regarding eye infections and suggests not purchasing certain eye drops. It included the eye drop manufactured by Target Corporation.
What Price Action is Indicating About the Target Corporation Stock?
The TGT stock price has formed a falling wedge pattern on the daily chart and recently given a breakdown. The sellers were able to hold the price below the pattern and confirmed the authenticity of the breakdown. At present, the stock price is trying to form a base for the next big move and it seems like it is preparing for a fall.
The TGT stock price has been trading in a range since the beginning of October. It is facing resistance near the $113.16 level. Apart from that, the next resistance is present at the level of $124.53. The stock price has taken support from the level of $103.03 and $85.66 is the next support for the price.
An Overview of the EMAs and Relative Strength Index
The TGT stock price is trading well below the 200-day Exponential Moving Average and facing resistance from the 50-day EMA. The slope of the 50- EMA is curving more downwards, which indicates that the selling is getting aggressive.
The relative strength index is also below the 39.52 level, which also suggests bearishness in the price.
Conclusion
Several rating firms are suggesting buying the TGT stock and the stock is falling continuously. The FDA’s advisory against the eye drops manufactured by Target Corp can also create some selling pressure ahead. If the stock price breaks the support level of $103.03, it can move toward the level of $85.66.
Technical level
Resistance – $113.16 and $124.53
Support – $103.03 and $85.66
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational purposes only. They do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.
